Building a Blockchain Application: A Show Case for Healthcare Providers and Insurance Companies

Author(s):  
Kawther Saeedi ◽  
Arwa Wali ◽  
Dema Alahmadi ◽  
Amal Babour ◽  
Faten AlQahtani ◽  
...  
Author(s):  
Valeria Cardenas ◽  
Anna Rahman ◽  
Yujun Zhu ◽  
Susan Enguidanos

Background: Despite some insurance plans now paying for home-based palliative care, recent reports have suggested that insurance coverage for palliative care may be insufficient in expanding patient access to home-based palliative care. Aim: To identify patients’ and caregivers’ perceived barriers to home-based palliative care and their recommendations for overcoming these barriers. Design: We conducted a qualitative study using semi-structured individual interviews. Our interview protocol elicited participants’ perspectives on home-based palliative care services; positive and negative aspects of the palliative program explanation; and suggestions for improving messaging around home-based palliative care. Setting/Participants: Twenty-five participants (patients, proxies, and their caregivers) who were eligible for a randomized controlled trial of home-based palliative care were interviewed by telephone. Results: Themes related to home-based palliative care referral barriers included reluctance to have home visits, enrollment timing, lack of palliative care knowledge, misconceptions about palliative care, and patients’ self-perceived health condition. Themes related to recommendations for overcoming these obstacles included ensuring that palliative care referrals come from healthcare providers or insurance companies and presenting palliative care services more clearly. Conclusion: Findings reinforce the need for additional palliative care education among patients with serious illness (and their caregivers) and the importance of delivering palliative care information and referrals from trusted sources.


Author(s):  
Keith S. Karn ◽  
Andrew Golaszewski

Insurance companies, healthcare providers, and patients are realizing we can treat many medical issues at home and avoid expensive and often inconvenient visits to the doctor’s office or hospital. As a result, many medical devices are now in the hands of untrained patients and caregivers, creating a growing market of consumer medical (or “medsumer”) products. This medsumer product market is exploding, along with the increased spending on home healthcare. This paper explores the benefits and value of looking at medical product development through the lens of this medsumer trend by applying typically consumer-oriented tools and techniques to the development of medical devices. We recommend specific consumer-driven techniques and tools we have used recently in developing medical products. The techniques include a greater emphasis on up-front user research, technological augmentation to ethnography, interdisciplinary design approach, integrated physical & digital prototyping, and more iterative user feedback.


Author(s):  
Michael E. Schatman

Even though the efficacy of interdisciplinary pain management programs is supported, their numbers have decreased and the vast majority of Americans with chronic pain do not have access to them. Insurance companies do not want to pay for these services, hospitals believe they are financial losers, and the opioid crisis has placed a pall over the practice of pain medicine. The demise of these programs has left pain medicine in a fragmented state. Few healthcare providers who treat chronic pain patients have the time to coordinate care by multiple professionals The opioid crisis seen in certain areas, such as Appalachia, may be related to the lack of these interdisciplinary programs. There should be concerted efforts to increase access to and funding of these programs. Although they are not a panacea for all types of chronic pain, they can improve patients’ well-being and function and reduce their need for opioid medications.


Author(s):  
Manimay Dev ◽  
Dinesh Kumar ◽  
Dharmendra Patel

Purpose The purpose of this paper is to identify the factors that influence hospitals’ selection by health-care insurers in India and to establish a hierarchical model representing the relationship among different factors and their influence on the entire scenario. Design/methodology/approach A survey with a set of questionnaires was conducted with different health-care insurer executives of reputed health insurance companies. The data has been gathered by using a five-point Likert scale. Their opinions were converted into a reachability matrix and an interpretive structural modeling was constructed. The final results obtained were verified by using fuzzy Matriced Impacts Croises-Multiplication Applique and Classement analysis. Findings The results suggested three key driving factors, National Accreditation Board for Hospitals & Healthcare Providers accreditation of the hospital, purchasing power of people in the region and national and international recognition of the hospital among the eleven factors selected for the study. Research limitations/implications The research mainly focuses on the health insurance benefits provided by privately owned insurance companies and do not comment on any government’s mass health insurance scheme. Practical implications With a small proportion of people under the umbrella of health insurance in India, these factors will assist and expedite insurer’s effort to penetrate deep into rural and urban areas enhancing availability and escalating affordability. Originality/value This paper presents key factors responsible for better coordination between health-care systems and insurance companies.


2018 ◽  
Vol 8 (1) ◽  
pp. 37-42
Author(s):  
Shaikh Hussain ◽  
Rubina Hussain ◽  
Assad Hafeez ◽  
Adnan Khan

Background: Prime Minister's National Health Programme (PMNHP) is a publically funded cashless scheme at point of service, which was initiated in December 2015 to provide access to universal healthcare to people living below poverty line for indoor secondary and tertiary healthcare services for priority diseases in Pakistan. Objective: Our study aimed to compare prices of PMNHP districts packages, compare PMNHP with average payments made to healthcare providers by various health insurance companies, and compare prices among PMNHP itself, public sector not supported by the programme, and private healthcare not supported by the programme in Islamabad Methods: We conducted this comparative descriptive cross sectional study. For first two objectives, we collected secondary data, and for the third objective, we did convenient sampling of the treated patient (n-158) from PMNHP, public and private hospitals for selected diseases. Results: PMNHP district comparisons showed no significant difference among districts except Normal Delivery (NVD) at Rahim Yar Khan had lowest cost (mean=10111.11). For Diabetes Mellitus, Muzaffarabad had lowest (mean=1733.33), and Quetta had highest (mean=5300). Average price paid to healthcare providers by various insurance companies are on higher side as compared to PMMHP. Price differences were significant among PMNHP, Public Out of Pocket Spending (OOPS) and Private For NVD, [F(2, 27)=3364, p=0.000] with PMNHP (mean=15.000, SD=0.000) Public (OOPS) (mean=2.127, SD=0.221) and Private (mean=14.702, SD=0.658) For caesarian section [F(2,27)=2850, p=0.000], and Cholecystectomy, [F(2, 28)=221, p=0.000]. While in comparison with Private, PMNHP were cost beneficial for caesarian section (mean=32.016, SD=1.31) and Cholecystectomy (m=43.133, SD=6.648). Conclusion: PMNHP district wise packages are almost same among and for all the districts. Program is fairly and competitively priced against public and private healthcare providers, and private health insurance healthcare provider payments. PMNHP design features may be used to extend program in other districts.  


2008 ◽  
Vol 139 (2_suppl) ◽  
pp. P41-P42
Author(s):  
James Y Suen ◽  
Lisa M Buckmiller ◽  
Chun-Yang Fan ◽  
Gal Shafirstein ◽  
Robert Glade

Objective 1) To demonstrate the natural history of arteriovenous malformation (AVMs) when left untreated or inadequately managed. 2) To demonstrate the need for major treatment to patients, families, healthcare providers, and insurance companies. Methods Records from 10 of 50 representative patients treated at University of Arkansas for Medical Sciences (UAMS) for advanced AVMs were reviewed for age at presentation, gender, presenting symptoms, previous treatment, disease course, and post-presentation management. Patients were asked if quality of life had improved after treatment at UAMS Facial photos from childhood were obtained and compared with photos taken at time of presentation. Results 10 patients (7 male, 3 female, range 21–46 years) received treatment. All patients presented with bleeding, pain and/or facial destruction. 6 of 10 patients received previous embolization. No patients had undergone previous surgical resection. All were informed by a previous physician that the disease was incurable or treatment options had been exhausted. All patients experienced subsequent worsening of symptoMS All patients were treated at UAMS with preoperative embolization followed by surgical resection and required multiple surgeries to remove persistent AVM. All patients indicated quality of life improved after embolization/surgical resection. Comparison of photos revealed progression of disease in all cases marked by facial destruction and deformity. Conclusions AVMs display a progressive and destructive nature when left untreated or inadequately managed. Natural history can be used to demonstrate to patients, families, and healthcare providers the seriousness of disease and convince insurance companies that radical treatment is typically necessary to obtain control or cure.


2020 ◽  
Vol 5 (1) ◽  

Owing to burgeoning improvements in surgical technology, anaesthesia and pain medicine, ambulatory anaesthesia for outpatient surgery has become commonplace, with a proportion of 66% in the United States of America, 50% in the United Kingdom, 11%-23% in India and an ambitious 75% in the next decade. Its advent was driven by financial and economic issues which it adequately abates by 25%-75% lesser than an inpatient procedure. Among other benefits to patients, healthcare providers, insurance companies and hospitals, outpatient anaesthesia decreases costs, minimises respiratory failure, enhances early hospital discharge, contributes to the economic growth of the nation, and decreases exposure to nosocomial infections. The growing complexity of surgical methods and number of comorbidities these days have increased the indications for ambulatory anaesthesia. In order for it to be safe and successful, the appropriate selection of patients, surgical and anaesthetic methods as well as postoperative management should be considered simultaneously. Nevertheless, ambulatory anaesthesia is still hindered by limited resources, inadequate expertise, and poor coordination between medical and organisational aspects of care in some countries. This problem can be minimized by providing resources and the training of healthcare providers on better organisation and the use and manipulation of these equipment through seminars and conferences. Furthermore, the global burden of disease study projects an increase in future anaesthesia demands due to the ever rising disease burden worldwide. This can be resolved by adequately managing the challenges of ambulatory anaesthesia and creating more centers either within or without hospitals. By and large, safe and convenient cost-effective methods to ensure patient’s quick return to function and recovery are necessary in ambulatory anaesthesia. Still and all, many challenges are being confronted daily, and numerous barriers have to be broken before ambulatory anaesthesia and surgery can make its concrete place and establishment in the clinical society.


2011 ◽  
pp. 2111-2124 ◽  
Author(s):  
Ebrahim Randeree

An increasing focus on e-health and a governmental push to improve healthcare quality while giving patients more control of their health data have combined to promote the emergence of the personal health record (PHR). The PHR addresses timeliness, patient safety, and equity, goals that the Institute of Medicine has identified as integral to improving healthcare. The PHR is vital to the National Health Information Network (NHIN) that is being developed to give all Americans access to electronic health records by 2014. Despite increasing public access to PHRs via employers, insurance companies, healthcare providers, and independent entities, it is unclear whether the PHR will be successfully implemented and adopted by the public. This chapter looks at how PHRs address the needs, desires, and expectations of patients, explores the data quality concerns regarding patient-generated information (data capture, sharing and integration with other systems), discusses social implications of adoption, and concludes with a discussion of the evolving role that PHRs play in the growth of patient-centered e-health.


Author(s):  
Rachel Proffitt

Rehabilitation is complex. It involves an ever-changing interaction of the rehabilitation patient with different clinical environments and healthcare providers. Gamification for rehabilitation goes beyond simply creating a “fun” and “exciting” application or environment in which to complete rehabilitation exercises and interventions. A delicate balance of the demands of the task and the patient's abilities must be achieved. High-cost and commercially available systems are limited in their applications to gamification for rehabilitation. Furthermore, the created game and system must be usable across treatment settings and at different phases in the recovery process. Insurance companies are also requiring more data from rehabilitation therapists and therapists have minimal time to be able to learn and use a game. Pairing low-cost devices with customized games will allow for better “fit” with each patient, provide appropriate data to therapists and insurance companies, and eventually lead to effective games for rehabilitation.


Sign in / Sign up

Export Citation Format

Share Document